Clinical trials in Rwanda
158 studies list at least one site in Rwanda. 25 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 111
- Recruiting
- 13
- Status unknown
- 13
- Not yet recruiting
- 11
- Active, not recruiting
- 4
- Withdrawn
- 3
Phase
- Phase 3
- 18
- Phase 2
- 17
- Phase 1
- 15
- Phase 4
- 8
- Early Phase 1
- 1
Most studied here
Who runs them
Ministry of Health, Rwanda (9) · Brigham and Women's Hospital (7) · University of Rwanda (6) · University of Birmingham (6) · Boston College (5) · Novartis Pharmaceuticals (5) · International AIDS Vaccine Initiative (5) · Janssen Vaccines & Prevention B.V. (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 158 — search for more.
- Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 RwandaNot yet recruitingNCT07390916Not applicable
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)RecruitingNCT07811908Phase 2
- Association of Gestational Cardiovascular Health With Pregnancy OutcomesRecruitingNCT05776082
- Heart Failure Self Care Education in RwandaNot yet recruitingNCT07722468Not applicable
- Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight EstimationRecruitingNCT07661433
- Breast and Cervical Cancer Stigma in RwandaNot yet recruitingNCT07663006Not applicable
- Smart Discharges for Older ChildrenRecruitingNCT07629154
- Strategies to Decentralize Breast Ultrasound in RwandaNot yet recruitingNCT06812208Not applicable
- Adjuvant Endocrine Therapy Adherence Intervention Pilot in RwandaNot yet recruitingNCT07562399Not applicable
- Evaluation of an mHealth-CHW Tool for Post-c-section Follow-up in Rural RwandaEnrolling by invitationNCT07369700Not applicable
- Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in RwandaNot yet recruitingNCT07548021Phase 1
- Rwanda Digital Dashboard Hybrid Type 3 Implementation StudyRecruitingNCT06941831Not applicable
- Bag CPAP vs Standard Oxygen Therapy in Acute Hypoxemic Respiratory FailureNot yet recruitingNCT07460427Not applicable
- TETANUS Antibody Detection in Saliva StudyNot yet recruitingNCT07446166Not applicable
- EMUs: Enhanced Monitoring Using Sensors After SurgeryRecruitingNCT06565559
- Health Systems and Policy Contexts of Medical OxygenRecruitingNCT06169514
- A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 MedicinesRecruitingNCT05951595Phase 3
- A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 MonthsRecruitingNCT07036159Phase 2
- Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)RecruitingNCT05580666Phase 3
- Reducing Deaths After Surgery in Low- and Middle-income Countries: A Pilot Cluster Randomised TrialNot yet recruitingNCT06932653Not applicable
- A Global Prospective Cohort Study on Outcomes of Appendicectomy for AppendicitisRecruitingNCT06774001
- Mpox Comprehensive Assessment for Responsive Immunisation in Emergency OutbreaksRecruitingNCT06887556Not applicable
- Testing and Comparing the Impacts of Mhealth-Based and Web-Based Education on Oral CancerNot yet recruitingNCT06711848Not applicable
- A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSINot yet recruitingNCT06465901Not applicable
- Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant TuberculosisRecruitingNCT05555303Phase 2
- Postpartum Family Planning Program in RwandaActive, not recruitingNCT05056545Not applicable
- Building Respiratory Support in East Africa Through High Flow Versus Standard Flow Oxygen EvaluationActive, not recruitingNCT05754034Not applicable
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)CompletedNCT07811882Phase 2
- The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIVCompletedNCT02295800
- DEUX OEUFs: Cracking the Potential of Eggs to Improve Child Growth and DevelopmentTerminatedNCT06405360Not applicable
- Multifamily Healing Spaces for Family Resilience in RwandaCompletedNCT07621705Not applicable
- Pathway-Matched Resilience-Oriented Therapy in RwandaCompletedNCT07621731Not applicable
- Household Air Pollution and Health: A Multi-country LPG Intervention TrialCompletedNCT02944682Not applicable
- Transfusion Camp for Medical Students in RwandaCompletedNCT06259734Not applicable
- To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum MalariaCompletedNCT04675931Phase 2
- The Impact of First Aid Blended Learning Training on Learning Outcomes and Helping Behaviour of Adult Laypeople in RwandaCompletedNCT06003504Not applicable
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedNCT05842954Phase 3
- Sustainable Household Energy Adoption in Rwanda (SHEAR)CompletedNCT05668624Not applicable
- Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.Active, not recruitingNCT06436274Phase 4
- HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based RegimenCompletedNCT06285110
- A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.CompletedNCT03923725Phase 3
- HPV Vaccine Effectiveness Study in Rwandan Women Living With HIVCompletedNCT05247853
- The Sugira Muryango Longitudinal & Spillover StudyCompletedNCT05405400
- East Africa Point of Care Viral Load StudyCompletedNCT05048472Not applicable
- Dynamic CDSA to Manage Sick Children in RwandaCompletedNCT05108831Not applicable
- Strongyloides Stercoralis Public Health Control in RwandaCompletedNCT07009613
- Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected AdultsCompletedNCT02788045Phase 1/2
- A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Tetravalent Ad26.Mos4.HIV Along With Either Clade C gp140 Plus Adjuvant OR With a Combination of Mosaic and Clade C gp140 Plus Adjuvant in Healthy HIV Uninfected AdultsCompletedNCT02935686Phase 1/2
- Community Health Workers-led Multicomponent Intervention for Hypertension Control in RwandaCompletedNCT06959134Not applicable
- Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African AdultsCompletedNCT04173819Phase 1/2